CENiMED Announces Certification According To GLP Standard
July 30th, 2007 by 
Barry - Admin BioPharmArena
CENiMED GmbH, the leading provider of pharmacogenomic services in Germany announces its certification according to international Good Laboratory Practice (GLP) standard by the German authorities, Landesamt für Arbeitsschutz, Gesundheitsschutz und technische Sicherheit Berlin (LAGetSi). The certification applies to pharmakogenomic analyses for the in-vitro determination of the genotype and phenotype as well as to gene expression analyses.
Dr. Volker Muschalek, CEO of CENiMED GmbH, states: “This makes CENiMED GmbH the first and only laboratory in Europe which is able to generate pharmacogenomic data accepted by the regulatory agencies (FDA, EMEA). Since years the agencies strongly recommend the submission of pharmacogenomic data for the approval process of new drugs. Apart from that we are very happy that we can now also offer gene expression analyses with Affymetrix technology as the only laboratory in Europe.”
Dr. Dirk Sawitzky, COO of CENiMED GmbH comments: „This certification reflects the successful implementation of highest international quality standards at CENiMED GmbH and is another milestone in the flourishing development of our young company.”
Posted in News, Regulatory Affairs, Quality Assurance | 